Preparation of the endometrium for ablation with a single dose of leuprolide acetate depot.

In: The Journal of reproductive medicine · 1991 · vol. 36(7) , pp. 477–8 · PMID:1941784 · W2463143389
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

A single 7.5 mg depot injection of leuprolide acetate administered pre-ablation thinned the endometrium, reduced its vascularity, and induced atrophy in eight women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Several reports describe enhancing the efficacy of laser or resectoscopic endometrial ablation procedures by preparing the endometrium with danazol or progestin therapy. Because gonadotropin releasing hormone agonists have been found to inhibit the thickness and development of the endometrial lining, preparation of the endometrium for resectoscopic ablation was attempted on eight women using a single injection of 7.5 mg of leuprolide acetate depot. When the ablation was performed, one month after the injection of the medication, which had occurred on day 20-24 of the prior menstrual cycle, the endometrium was thinned in all the patients, with inactive glands, reduced vascularity and atrophic stroma.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

openalex
last seen: 2026-05-10T10:29:58.231670+00:00
License: CC0 · commercial use OK